Emerging Anticoagulant Drugs Journal Articles

abstract

• Abstract—The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.

authors

• Bates, Shannon
• Weitz, Jeffrey

status

• published 

publication date

• September 2003

has subject area

• 1102 Cardiorespiratory Medicine and Haematology (FoR)
• 1103 Clinical Sciences (FoR)
• Animals (MeSH)
• Anticoagulants (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Contraindications (MeSH)
• Humans (MeSH)

published in

• Arteriosclerosis, Thrombosis and Vascular Biology  Journal

keywords

• Animals
• Anticoagulants
• Contraindications
• Humans

Digital Object Identifier (DOI)

• 10.1161/01.atv.0000084827.77945.66

PubMed ID

• 12842845

start page

• 1491

end page

• 1500

volume

• 23

issue

• 9